申请人:Sanraku Incorporation
公开号:US04855421A1
公开(公告)日:1989-08-08
The invention relates to new 2-oxoazetidines having the formulas ##STR1## where R.sub.1 stands for a lower fluoroalkyl or an optionally protected lower hydroxyalkyl group; R.sub.2 for chlorine, bromine, iodine, fluorine, an ##STR2## group in which n is 0, 1 or 2 and R.sub.5 is a lower alkyl, lower alkenyl, an optionally substituted benzyl group, optionally substituted phenyl group, a --CH.sub.2 COX group in which X means a lower alkyl, lower alkoxy or the amino group, or a ##STR3## group in which Y and Z are the same or different and in each case stand for oxygen, nitrogen or sulphur and R.sub.6 stands for a lower alkyl, lower alkoxy, lower alkylthio, lower dialkylamino, an aryl, aryloxy or arylthio group, or for a group having the formula ##STR4## where W stands for --CH.sub.2 CH.sub.2 --, --CH.dbd.CH-- or C.sub.6 H.sub.4 ; R.sub.3 stands for bromine, chlorine, iodine, SeC.sub.6 H.sub.5 or SC.sub.6 H.sub.5 ; and R.sub.4 stands for hydrogen, a group having the formula ##STR5## in which R.sub.7 is a lower alkyl, an optionally substituted benzyl or an optionally substituted benzohydryl group; or they represent a protecting group, with the proviso that in compounds of formula Ia R.sub.2 does not stand for SCH.sub.3 when R.sub.1 means hydroxyethyl, R.sub.3 means bromine and R.sub.4 means the group of formula IIa, as well as to methods for their preparation and to their use.
本发明涉及具有以下式子的新型2-氧代
吡嗪:##STR1##其中,R.sub.1代表较低的
氟代烷基或可选的保护较低的羟基烷基;R.sub.2代表
氯、
溴、
碘、
氟、##STR2##其中n为0、1或2,R.sub.5为较低的烷基、较低的烯基、可选地取代的苄基、可选地取代的苯基、--CH.sub.2 COX基,其中X表示较低的烷基、较低的烷氧基或
氨基,或者##STR3##其中Y和Z相同或不同,分别代表氧、氮或
硫,R.sub.6代表较低的烷基、较低的烷氧基、较低的烷
硫基、较低的二烷基
氨基、芳基、芳氧基或芳
硫基,或者代表具有以下式子的基团##STR4##其中W代表--CH.sub.2 CH.sub.2 --、--CH.dbd.CH--或C.sub.6 H.sub.4;R.sub.3代表
溴、
氯、
碘、SeC.sub.6 H.sub.5或SC.sub.6 H.sub.5;R.sub.4代表氢、具有以下式子的基团##STR5##其中R.sub.7为较低的烷基、可选地取代的苄基或可选地取代的苯甲酰基基团;或它们代表保护基,但有条件地,在式Ia的化合物中,当R.sub.1代表羟乙基,R.sub.3代表
溴,R.sub.4代表式IIa的基团时,R.sub.2不代表SCH.sub.3。本发明还涉及其制备方法和用途。